DE69517050T2 - Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie - Google Patents

Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie

Info

Publication number
DE69517050T2
DE69517050T2 DE69517050T DE69517050T DE69517050T2 DE 69517050 T2 DE69517050 T2 DE 69517050T2 DE 69517050 T DE69517050 T DE 69517050T DE 69517050 T DE69517050 T DE 69517050T DE 69517050 T2 DE69517050 T2 DE 69517050T2
Authority
DE
Germany
Prior art keywords
fatty acids
pct
cosmetology
stabilizing
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69517050T
Other languages
English (en)
Other versions
DE69517050D1 (de
Inventor
Jean-Robert Grinda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69517050D1 publication Critical patent/DE69517050D1/de
Application granted granted Critical
Publication of DE69517050T2 publication Critical patent/DE69517050T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/50—Use of additives, e.g. for stabilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DE69517050T 1994-07-15 1995-07-17 Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie Expired - Fee Related DE69517050T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408810A FR2722410B1 (fr) 1994-07-15 1994-07-15 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique

Publications (2)

Publication Number Publication Date
DE69517050D1 DE69517050D1 (de) 2000-06-21
DE69517050T2 true DE69517050T2 (de) 2001-01-18

Family

ID=9465440

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69517050T Expired - Fee Related DE69517050T2 (de) 1994-07-15 1995-07-17 Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie

Country Status (14)

Country Link
US (1) US5914347A (de)
EP (1) EP0796238B1 (de)
JP (1) JPH10508287A (de)
KR (1) KR100388818B1 (de)
AT (1) ATE193006T1 (de)
DE (1) DE69517050T2 (de)
DK (1) DK0796238T3 (de)
ES (1) ES2150004T3 (de)
FR (1) FR2722410B1 (de)
GR (1) GR3033990T3 (de)
MX (1) MX9701771A (de)
NZ (1) NZ289877A (de)
PT (1) PT796238E (de)
WO (1) WO1996002488A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
DK0894142T4 (da) * 1996-03-28 2014-02-24 Dsm Ip Assets Bv Mikrobiel olie der omfatter en polyumættet fedtsyre og proces til produktion af olie fra pasteuriseret og granuleret biomasse.
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) * 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2777827C (en) * 2009-10-30 2020-08-18 Retrotope, Inc. Alleviating oxidative stress disorders with pufa derivatives
EP2708230A4 (de) * 2011-05-12 2014-12-03 Nippon Suisan Kaisha Ltd Zusammensetzung zur äusserlichen anwendung auf der haut für entzündliche erkrankungen
WO2015083806A1 (ja) 2013-12-04 2015-06-11 日本水産株式会社 微生物油、微生物油の製造方法、濃縮微生物油及び濃縮微生物油の製造方法
ES2871130T3 (es) 2015-11-23 2021-10-28 Retrotope Inc Marcado isotópico específico del sitio de sistemas de 1, 4-dieno
EP4107163A1 (de) 2020-02-21 2022-12-28 Retrotope, Inc. Verfahren zur isotopenmodifizierung von mehrfach ungesättigten fettsäuren und deren derivaten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
JPS60258139A (ja) * 1984-06-05 1985-12-20 Nippon Oil & Fats Co Ltd 金属石けんの水分散体
FR2573653B1 (fr) * 1984-11-23 1988-02-26 Pf Medicament Compositions pharmaceutiques antiandrogenes a base d'acides gras
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid

Also Published As

Publication number Publication date
KR100388818B1 (ko) 2003-10-17
FR2722410B1 (fr) 1996-10-04
DK0796238T3 (da) 2000-10-02
EP0796238A1 (de) 1997-09-24
KR970706230A (ko) 1997-11-03
PT796238E (pt) 2000-09-29
JPH10508287A (ja) 1998-08-18
FR2722410A1 (fr) 1996-01-19
EP0796238B1 (de) 2000-05-17
US5914347A (en) 1999-06-22
ES2150004T3 (es) 2000-11-16
MX9701771A (es) 1997-12-31
GR3033990T3 (en) 2000-11-30
ATE193006T1 (de) 2000-06-15
WO1996002488A1 (fr) 1996-02-01
DE69517050D1 (de) 2000-06-21
NZ289877A (en) 1998-05-27

Similar Documents

Publication Publication Date Title
DE69517050D1 (de) Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie
US5104655A (en) Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
US4963527A (en) Phospholipid complexes of extracts of vitis vinifera, their preparation process and pharmaceutical and cosmetic compositions containing them
KR101129996B1 (ko) 세라미드 유형 화합물의 합성 방법
DE69510190T2 (de) Verwendung von fettsäureester als bioklebstoffe
KR960016908A (ko) 제약학상 담체
ES2001512A6 (es) Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
JP3527754B2 (ja) ラノリン脂肪酸類の分離法及びそれらを用いた化粧料及び外用薬
BR0009340A (pt) Composição adequada para uso na pele ou no cabelo, produto para aplicação na pele ou no cabelo, método para preparar uma composição adequada para aplicação na pele ou no cabelo, e, uso de uma composição
EP0084341B2 (de) Mittel vom Emulsion-Typ für den äusserlichen Gebrauch
KR20060008913A (ko) 아스코르브산의 안정화된 유도체
JPS63284109A (ja) 美白化粧料
PL339255A1 (en) Hair treating composition
HUP0004981A2 (hu) Aminofenolszármazékot tartalmazó kozmetikai készítmény, ennek alkalmazása és eljárás aminofenol származékok oldására
JPH03505089A (ja) 化粧用および薬用局所製剤
JP2003081778A (ja) 養育毛剤
JP2001302525A (ja) 皮膚外用剤
JP3219432B2 (ja) 皮膚外用剤
JPH09157138A (ja) 養育毛剤
JP2009221144A (ja) 表皮バリアー機能向上剤
KR20020067681A (ko) 육모제
JPH08165231A (ja) 光老化防止剤及びそれを配合してなる皮膚化粧料
JPH09157136A (ja) 養育毛剤
JPH0286788A (ja) 脂肪酸の製造方法および養毛育毛剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee